Table 3. Tuberculosis treatment outcomes, by presence of probable depression, Ethiopia, 2014–2016.
| Indicator | Participantsa |
P | |
|---|---|---|---|
| With probable depression at baseline(n = 309) | Without probable depression at baseline(n = 266) | ||
| Treatment outcome, no. (%) | |||
| Treatment success | 269 (87.1) | 257 (96.6) | < 0.001 |
| Treatment failure | 4 (1.3) | 2 (0.8) | ND |
| Treatment default | 12 (3.9) | 2 (0.8) | < 0.05 |
| Death | 24 (7.8) | 5 (1.9) | < 0.01 |
| Quality-of-life score, mean (SD)b,c | |||
| At baseline before tuberculosis treatment | 4.7 (2.7) | 5.7 (2.4) | < 0.001 |
| After 6 months of treatment | 5.0 (2.4) | 6.0 (2.2) | < 0.001 |
| Disability score, median(IQR)c,d | |||
| At baseline before tuberculosis treatment | 30 (16) | 18 (8) | < 0.001 |
| After 6 months of treatment | 22 (19) | 14 (4) | < 0.001 |
IQR: interquartile range; ND: not determined; SD: standard deviation.
a Treatment outcomes were known at 6 months for 575 of the 648 study participants: those who refused to be tested, were transferred to another area or whose diagnosis changed were excluded.
b Quality of life was assessed using the question, “How would you rate your health-related quality of life?” and scored from 0 (worst) to 10 (best).
c Quality-of-life and disability were assessed in 648 participants at baseline and in 532 at 6 months.
d Disability was assessed using the interviewer-administered version of the 12-item World Health Organization Disability Assessment Schedule, version 2.0 (score range: 0 to 60).23